Folate shows limited impactEffects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial.
Low relevance due to treatment pairing.
We aimed to understand how treatments with folate in combination with tetracycline affect bloating in patients recovering from giardiasis. In a well-structured clinical trial, two groups received different treatments: one group was given a combination of albendazole and metronidazole for a week, while the other received tetracycline alongside folic acid for four weeks. The key focus was on symptom improvement, particularly bloating.
Both treatment groups noticed some reduction in overall symptoms by the end of the treatment period, with the tetracycline and folate group showing a more significant improvement. Notably, patients in both groups experienced a decrease in bloating, which is a common and uncomfortable symptom in gastrointestinal issues.
However, a month after the treatments, the number of patients reporting ongoing improvements was quite low. Additionally, symptoms, including bloating, returned over time, and by the end of the year, there was no lasting change in overall symptom scores for either group. This suggests that while folate and other treatments may provide short-term relief, they do not lead to long-standing benefits in managing persistent bloating following a Giardia infection. Ultimately, the reasons for ongoing bloating and discomfort remain unclear and deserve further investigation.
Read More